Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Biogen is a global leader in biotechnology, dedicated to pioneering therapies for severe neurological diseases. The company researches, develops, and markets innovative treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. Biogen is committed to improving the lives of patients worldwide through its advancements in neuroscience.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Biogen is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Biogen last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at 3.60 USD.
Across its last 4 earnings reports, Biogen stock moved by ±4.9% on average the following day. The largest reaction was +8.5% on 02/06/2026; 2 of 4 reactions were positive.
Biogen has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.